Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Untethered Proteins Could Help Diagnose MKD

By LabMedica International staff writers
Posted on 30 May 2017
Mevalonate Kinase Deficiency (MKD), also known as HIDS (hyper IgD syndrome), is a rare genetic condition that affects approximately 200 individuals worldwide. More...
It is a spectrum of disease, with complications that range from mild to severe. MKD is one of more than 8,000 known rare and genetic conditions, which, although individually uncommon, collectively affect up to 10% of the population.

Individuals with MKD experience recurrent and frequent attacks of high fever, which are associated with pain in the joints, muscles and abdomen, along with skin rash. Attacks of fever can last for several days and occur periodically throughout life. In its severest form, also known as mevalonic aciduria, MKD can be life-threatening, and can involve neurological symptoms and impaired growth.

Scientists at the Garvan Institute of Medical Research developed a highly sensitive in vitro prenylation assay that enables the detection of unprenylated small GTPase proteins in cell lysates. Human peripheral blood monocytes (PBMCs) were isolated from buffy coat preparations of fresh blood samples and cell pellets were snap frozen before analysis. The scientists performed Western blots and in vitro prenylated (i.e., biotinylated) proteins were detected on polyvinylidene difluoride blots using streptavidin-680RD. Blots were also analyzed for unprenylated Rap1A using goat anti-Rap1A.

The team showed that, within the cells, several proteins from the same family (known as Rab proteins) had no isoprenoid 'tail', a molecule that is usually added to these proteins in the final stages of preparing them for their work in the cell. An isoprenoid tail is thought to act as a molecular 'tether' for the protein it is attached to. The isoprenoid tails on Rab proteins keep them in a particular area of the cell close to the cell membrane. Without their tethers, the Rab proteins, and other related proteins, are 'on the loose' in the cells of children with MKD, and are free to move into other parts of the cell. It is thought that this could set off the disease process in MKD, triggering inflammation. Untethered Rab proteins are found only in people in MKD. They are not present in the cells of people with other rare diseases that have similar clinical symptoms (the periodic fever syndromes) or in the parents of children with MKD.

Michael J. Rogers, PhD, a professor and chief investigator, said, “It has been thought for some time that individuals with MKD might have untethered Rab proteins, because we know that a gene called mevalonate kinase (MVK), which is altered in MKD, is important in making the isoprenoid tails that are fitted onto these proteins. Until now, though, no one has been able to show that these untethered proteins do in fact build up in the cells of kids with MKD. To see these proteins directly, and to show that they are lacking their ‘tails’ is an important advance in our understanding of this devastating disease.” The study was published on May 10, 2017, in the Journal of Allergy and Clinical Immunology.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Drug Testing Assays
Atellica DT 250 Analyzer
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.